Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study

1. Boni, V.
2. Pistilli, B.
3. Braña, I.
4. Shapiro, G.I.
5. Trigo, J.
6. Moreno, V.
7. Castellano, D.
8. Fernández, C.
9. Kahatt, C.
10. Alfaro, V.
11. Siguero, M.
12. Zeaiter, A.
13. Longo, F.
14. Zaman, K.
15. Antón, A.
16. Paredes, A.
17. Huidobro, G.
18. Subbiah, V.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.ESMOOP.2022.100571 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus